⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIAFW News
bioAffinity Technologies, Inc. Warrant
Form 8-K
sec.gov
BIAF
BIAFW
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAF
BIAFW
bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic
businesswire.com
BIAFW
BIAF
Form 8-K
sec.gov
BIAF
BIAFW
Form 8-K
sec.gov
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
Form 8-K
sec.gov
BIAFW
BIAF
bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board
businesswire.com
BIAFW
BIAF